Pharma Times -- GlaxoSmithKline has outlined plans to become carbon-neutral by 2050 and increase its efforts to improve access to medicines in poor countries.
Pharma Times -- GlaxoSmithKline has outlined plans to become carbon-neutral by 2050 and increase its efforts to improve access to medicines in poor countries.